Latest news
BIAF: Strong CyPath® Lung growth drives Q2 2026, but liquidity concerns persist amid ongoing losses - TradingViewTradingView · Fri, 07 Aug 2026 20:49:59 GMTbioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 12:00:00 GMTPress Release: BioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath(R) Lung - MoomooMoomoo · Fri, 07 Aug 2026 12:00:00 GMT